Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by lklinares
Group name EquipeLL
Item Type Journal Article
Title A Chimeric Zika Virus between Viral Strains MR766 and BeH819015 Highlights a Role for E-glycan Loop in Antibody-mediated Virus Neutralization
Creator Frumence et al.
Author Etienne Frumence
Author Wildriss Viranaicken
Author Sandra Bos
Author Maria-Teresa Alvarez-Martinez
Author Marjolaine Roche
Author Jacques-Damien Arnaud
Author Gilles Gadea
Author Philippe Desprès
Abstract Zika virus (ZIKV) is an emerging mosquito-borne flavivirus which is of major public health concern. ZIKV infection is recognized as the cause of congenital Zika disease and other neurological defects, with no specific prophylactic or therapeutic treatments. As the humoral immune response is an essential component of protective immunity, there is an urgent need for effective vaccines that confer protection against ZIKV infection. In the present study, we evaluate the immunogenicity of chimeric viral clone ZIKBeHMR-2, in which the region encoding the structural proteins of the African strain MR766 backbone was replaced with its counterpart from the epidemic strain BeH819015. Three amino-acid substitutions I152T, T156I, and H158Y were introduced in the glycan loop of the E protein (E-GL) making ZIKBeHMR-2 a non-glycosylated virus. Adult BALB/c mice inoculated intraperitoneally with ZIKBeHMR-2 developed anti-ZIKV antibodies directed against viral proteins E and NS1 and a booster dose increased antibody titers. Immunization with ZIKBeHMR-2 resulted in a rapid production of neutralizing anti-ZIKV antibodies. Antibody-mediated ZIKV neutralization was effective against viral strain MR766, whereas epidemic ZIKV strains were poorly sensitive to neutralization by anti-ZIKBeHMR-2 immune sera. From our data, we propose that the three E-GL residues at positions E-152, E-156, and E-158 greatly influence the accessibility of neutralizing antibody epitopes on ZIKV.
Publication Vaccines
Volume 7
Issue 2
Pages 55
Date 2019-06-24
Journal Abbr Vaccines (Basel)
Language eng
DOI 10.3390/vaccines7020055
ISSN 2076-393X
Library Catalog PubMed
Extra PMID: 31238493 PMCID: PMC6630725
Tags arbovirus, chimeric virus, humoral response, mouse model, neutralizing antibody, original, viral clone, viral envelope protein
Date Added 2024/12/03 - 09:12:56
Date Modified 2024/12/03 - 09:12:56
Notes and Attachments PubMed entry (Attachment)
Texte intégral (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés